NSG530-Exam 2 Wilkes (Module 3,4,5)
Advanced Pathophysiology | 2026/2027
Edition | 100% Verified Questions,
Correct & Answers | Grade A+
Guaranteed Study Guide
Document Overview
Ace your first graduate nursing exam with the ultimate study companion for
NSG 530: Advanced Pathophysiology at Wilkes University. This
premium, comprehensive study resource is fully updated for the 2026
academic year and contains expert-verified practice questions explicitly
designed to mirror the actual exam format.
This resource is structured precisely around the official course blueprint to
ensure maximum study efficiency:
1. Question: What is autoimmunity?
Answer: A reaction of the immune response against one’s own tissues.
• Detailed Rationale: Autoimmunity occurs when the immune system loses its ability to
differentiate between "self" and "non-self" antigens. This breakdown leads to the
activation of T or B cells that mistakenly target and destroy the host's own healthy organs
and tissues, causing chronic inflammation and functional impairment.
2. Question: What is immune tolerance?
Answer: A state where self-antigens are not normally attacked because they are recognized
as "self" by the immune system.
• Detailed Rationale: Immunological tolerance is the mechanism by which the immune
system prevents an attack on the body's own tissues. Central tolerance occurs during
early development in the thymus and bone marrow (deleting self-reactive cells), while
1
, peripheral tolerance controls any self-reactive lymphocytes that escape into the rest of the
body.
3. Question: What is the most common systemic autoimmune disease?
Answer: Systemic lupus erythematosus (SLE).
• Detailed Rationale: SLE is a quintessential prototype of a multi-system, systemic
autoimmune disease. It is characterized by widespread inflammation, the production of
various autoantibodies (particularly antinuclear antibodies), and immune complex
deposition in multiple organs.
4. Question: What are some notable examples of organ-specific or
systemic autoimmune diseases?
Answer: Type 1 Diabetes Mellitus (DM), Multiple Sclerosis (MS), and Rheumatoid
Arthritis (RA).
• Detailed Rationale:
o Type 1 DM is an organ-specific autoimmune disease where T-cells selectively
destroy insulin-producing beta cells in the pancreas.
o MS involves an autoimmune attack on the myelin sheath protecting the nerves of
the central nervous system.
o RA is a systemic disease primarily characterized by immune-mediated, chronic
inflammation of the synovial joints.
5. Question: What is Systemic Lupus Erythematosus (SLE), and who
does it most commonly affect?
Answer: A chronic autoimmune inflammatory disease that affects many body systems and
occurs much more frequently in women than men.
• Detailed Rationale: SLE can affect the skin, joints, kidneys, brain, and blood vessels. It
exhibits a striking sex bias, affecting females roughly 9 times more often than males. This
predisposition is largely driven by estrogenic hormones, X-chromosome genetic factors,
and epigenetic variations.
2
,6. Question: What are the clinical manifestations of Systemic Lupus
Erythematosus (SLE)?
Answer:
• Arthralgias or arthritis
• Vasculitis and rash (e.g., malar/butterfly rash)
• Renal disease (lupus nephritis)
• Hematologic changes, especially anemia
• Cardiovascular disease (e.g., pericarditis)
• Detailed Rationale: The manifestations of SLE are highly diverse because
autoantibodies form immune complexes that trap themselves in small blood vessels
across the body. This triggers complement activation, leading to widespread tissue
damage—ranging from joint swelling and skin lesions to life-threatening kidney failure
and accelerated cardiovascular disease.
7. Question: Which laboratory screening test is typically positive in
Systemic Lupus Erythematosus (SLE)?
Answer: The ANA (Antinuclear Antibody) screen.
• Detailed Rationale: The ANA test measures antibodies that target the contents of a cell's
nucleus. It is highly sensitive for SLE (positive in >95% of cases), making it an excellent
initial screening tool. However, because it can be positive in other diseases or even
healthy individuals, a positive result must be followed by more specific tests (like anti-
dsDNA or anti-Smith antibodies).
8. Question: What is alloimmunity?
Answer: An immune reaction directed against the tissues of another individual of the same
species.
• Detailed Rationale: Also known as isoimmunity, alloimmunity happens when a person’s
immune system detects foreign antigens introduced from someone else. It is not an error
in self-recognition (like autoimmunity) but rather a normal, highly effective immune
system correctly identifying external human antigens as foreign.
9. Question: What are three classic examples of alloimmunity reactions?
3
, Answer: Transfusion reactions, transplant rejections, and the maternal immune response
to a fetus during pregnancy.
• Detailed Rationale: These three scenarios encapsulate how alloimmunity presents
clinically: introduction of foreign blood cells (transfusion), foreign solid organs
(transplant), or a genetically distinct half-foreign organism growing inside a host
(pregnancy, where specialized maternal-fetal mechanisms usually prevent rejection).
10. Question: What are alloantigens?
Answer: Nonself antigens found in members of the same species.
• Detailed Rationale: Alloantigens are genetically determined molecules that vary among
individuals within the same species. The most prominent examples in humans are the
ABO/Rh blood group antigens on red blood cells and the Major Histocompatibility
Complex (MHC/HLA) proteins on nucleated cells.
11. Question: What is a transfusion reaction?
Answer: A serious and potentially fatal complication of a blood transfusion in which a
severe immune response occurs because the patient's blood antibodies attack incompatible
antigens on the donated blood.
• Detailed Rationale: If a patient receives an incompatible blood type, their pre-existing
circulating antibodies immediately bind to the donor's red blood cells. This triggers
intravascular hemolysis (destruction of red blood cells), complement cascade activation,
and can lead to acute renal failure, disseminated intravascular coagulation (DIC), or
anaphylactic shock.
12. Question: Which blood type is designated as the universal donor?
Answer: Type O blood (specifically O negative).
• Detailed Rationale: Type O red blood cells lack both A and B surface antigens, meaning
they will not trigger an antibody attack when transfused into individuals with A, B, or AB
blood types. Type O negative also lacks the Rh (D) antigen, making it the safest choice
for emergency blood transfusions when the recipient's type is unknown.
4
Advanced Pathophysiology | 2026/2027
Edition | 100% Verified Questions,
Correct & Answers | Grade A+
Guaranteed Study Guide
Document Overview
Ace your first graduate nursing exam with the ultimate study companion for
NSG 530: Advanced Pathophysiology at Wilkes University. This
premium, comprehensive study resource is fully updated for the 2026
academic year and contains expert-verified practice questions explicitly
designed to mirror the actual exam format.
This resource is structured precisely around the official course blueprint to
ensure maximum study efficiency:
1. Question: What is autoimmunity?
Answer: A reaction of the immune response against one’s own tissues.
• Detailed Rationale: Autoimmunity occurs when the immune system loses its ability to
differentiate between "self" and "non-self" antigens. This breakdown leads to the
activation of T or B cells that mistakenly target and destroy the host's own healthy organs
and tissues, causing chronic inflammation and functional impairment.
2. Question: What is immune tolerance?
Answer: A state where self-antigens are not normally attacked because they are recognized
as "self" by the immune system.
• Detailed Rationale: Immunological tolerance is the mechanism by which the immune
system prevents an attack on the body's own tissues. Central tolerance occurs during
early development in the thymus and bone marrow (deleting self-reactive cells), while
1
, peripheral tolerance controls any self-reactive lymphocytes that escape into the rest of the
body.
3. Question: What is the most common systemic autoimmune disease?
Answer: Systemic lupus erythematosus (SLE).
• Detailed Rationale: SLE is a quintessential prototype of a multi-system, systemic
autoimmune disease. It is characterized by widespread inflammation, the production of
various autoantibodies (particularly antinuclear antibodies), and immune complex
deposition in multiple organs.
4. Question: What are some notable examples of organ-specific or
systemic autoimmune diseases?
Answer: Type 1 Diabetes Mellitus (DM), Multiple Sclerosis (MS), and Rheumatoid
Arthritis (RA).
• Detailed Rationale:
o Type 1 DM is an organ-specific autoimmune disease where T-cells selectively
destroy insulin-producing beta cells in the pancreas.
o MS involves an autoimmune attack on the myelin sheath protecting the nerves of
the central nervous system.
o RA is a systemic disease primarily characterized by immune-mediated, chronic
inflammation of the synovial joints.
5. Question: What is Systemic Lupus Erythematosus (SLE), and who
does it most commonly affect?
Answer: A chronic autoimmune inflammatory disease that affects many body systems and
occurs much more frequently in women than men.
• Detailed Rationale: SLE can affect the skin, joints, kidneys, brain, and blood vessels. It
exhibits a striking sex bias, affecting females roughly 9 times more often than males. This
predisposition is largely driven by estrogenic hormones, X-chromosome genetic factors,
and epigenetic variations.
2
,6. Question: What are the clinical manifestations of Systemic Lupus
Erythematosus (SLE)?
Answer:
• Arthralgias or arthritis
• Vasculitis and rash (e.g., malar/butterfly rash)
• Renal disease (lupus nephritis)
• Hematologic changes, especially anemia
• Cardiovascular disease (e.g., pericarditis)
• Detailed Rationale: The manifestations of SLE are highly diverse because
autoantibodies form immune complexes that trap themselves in small blood vessels
across the body. This triggers complement activation, leading to widespread tissue
damage—ranging from joint swelling and skin lesions to life-threatening kidney failure
and accelerated cardiovascular disease.
7. Question: Which laboratory screening test is typically positive in
Systemic Lupus Erythematosus (SLE)?
Answer: The ANA (Antinuclear Antibody) screen.
• Detailed Rationale: The ANA test measures antibodies that target the contents of a cell's
nucleus. It is highly sensitive for SLE (positive in >95% of cases), making it an excellent
initial screening tool. However, because it can be positive in other diseases or even
healthy individuals, a positive result must be followed by more specific tests (like anti-
dsDNA or anti-Smith antibodies).
8. Question: What is alloimmunity?
Answer: An immune reaction directed against the tissues of another individual of the same
species.
• Detailed Rationale: Also known as isoimmunity, alloimmunity happens when a person’s
immune system detects foreign antigens introduced from someone else. It is not an error
in self-recognition (like autoimmunity) but rather a normal, highly effective immune
system correctly identifying external human antigens as foreign.
9. Question: What are three classic examples of alloimmunity reactions?
3
, Answer: Transfusion reactions, transplant rejections, and the maternal immune response
to a fetus during pregnancy.
• Detailed Rationale: These three scenarios encapsulate how alloimmunity presents
clinically: introduction of foreign blood cells (transfusion), foreign solid organs
(transplant), or a genetically distinct half-foreign organism growing inside a host
(pregnancy, where specialized maternal-fetal mechanisms usually prevent rejection).
10. Question: What are alloantigens?
Answer: Nonself antigens found in members of the same species.
• Detailed Rationale: Alloantigens are genetically determined molecules that vary among
individuals within the same species. The most prominent examples in humans are the
ABO/Rh blood group antigens on red blood cells and the Major Histocompatibility
Complex (MHC/HLA) proteins on nucleated cells.
11. Question: What is a transfusion reaction?
Answer: A serious and potentially fatal complication of a blood transfusion in which a
severe immune response occurs because the patient's blood antibodies attack incompatible
antigens on the donated blood.
• Detailed Rationale: If a patient receives an incompatible blood type, their pre-existing
circulating antibodies immediately bind to the donor's red blood cells. This triggers
intravascular hemolysis (destruction of red blood cells), complement cascade activation,
and can lead to acute renal failure, disseminated intravascular coagulation (DIC), or
anaphylactic shock.
12. Question: Which blood type is designated as the universal donor?
Answer: Type O blood (specifically O negative).
• Detailed Rationale: Type O red blood cells lack both A and B surface antigens, meaning
they will not trigger an antibody attack when transfused into individuals with A, B, or AB
blood types. Type O negative also lacks the Rh (D) antigen, making it the safest choice
for emergency blood transfusions when the recipient's type is unknown.
4
